Regulation of myocardial interleukin-6 expression by p53 and STAT1

Journal of Interferon and Cytokine Research

Volumn 33, Issue 9, 2013, Pages 542-548

  Carroll, Christopher J ^a   Sayan, Berna S ^b   Bailey, Sarah G ^b   McCormick, James ^c   Stephanou, Anastasis ^c   Latchman, David S ^c   Townsend, Paul A ^b,c,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN P53; STAT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROBLAST; GENE INDUCTION; HEART FAILURE; HEART HYPERTROPHY; INFLAMMATION; ISOLATED HEART; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; CELL LINE; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; INTERLEUKIN-6; MICE; MICE, KNOCKOUT; MYOCARDIUM; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84883732229     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0165     Document Type: Article

References (28)

1. Angelo LS, Talpaz M, Kurzrock R. 2002. Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53. Cancer Res 62(3):932-940.
2. Durieux J, Wolff S, Dillin A. 2011. The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell 144(1):79-91.
3. Febbraio MA, Pedersen BK. 2005. Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? Exerc Sport Sci Rev 33(3):114-119.
4. Hirota H, Yoshida K, Kishimoto T, Taga T. 1995. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 92(11):4862-4866.
5. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD. 1998. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 95(13):7556-7561.
6. Kishimoto T. 2006. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 8 Suppl 2:S2.
7. Komarova EA, Krivokrysenko V, Wang K, Neznanov N, Chernov MV, Komarov PG, Brennan ML, Golovkina TV, Rokhlin OW, Kuprash DV, Nedospasov SA, Hazen SL, Feinstein E, Gudkov AV. 2005. p53 is a suppressor of inflammatory response in mice. FASEB J 19(8):1030-1032.
8. Kortekaas KA, Lindeman JH, Versteegh MI, van Beelen E, Kleemann R, Klautz RJ. 2013. Heart failure determines the myocardial inflammatory response to injury. Eur J Heart Fail 15(4):400-407.
9. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML. 1995. Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation 92(7):1866-1875.
10. Liao Z, Brar BK, Cai Q, Stephanou A, O'Leary RM, Pennica D, Yellon DM, Latchman DS. 2002. Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion. Cardiovasc Res 53(4):902-910.
11. Long X, Boluyt MO, Hipolito ML, Lundberg MS, Zheng JS, O'Neill L, Cirielli C, Lakatta EG, Crow MT. 1997. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest 99(11):2635-2643.
12. Matsui H, Ihara Y, Fujio Y, Kunisada K, Akira S, Kishimoto T, Yamauchi-Takihara K. 1999. Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-kappa B and NFIL6 in cardiac myocytes. Cardiovasc Res 42(1):104-112.
13. Matsusaka H, Ide T, Matsushima S, Ikeuchi M, Kubota T, Sunagawa K, Kinugawa S, Tsutsui H. 2006. Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice. Cardiovasc Res 70(3):457-465.
14. Matsushita K, Iwanaga S, Oda T, Kimura K, Shimada M, Sano M, Umezawa A, Hata J, Ogawa S. 2005. Interleukin-6/soluble interleukin-6 receptor complex reduces infarct size via inhibiting myocardial apoptosis. Lab Invest 85(10):1210-1223.
15. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84(3):431-442.
16. Paule B, Belot J, Rudant C, Coulombel C, Abbou CC. 2000. The importance of IL-6 protein expression in primary human renal cell carcinoma: an immunohistochemical study. J Clin Pathol 53(5):388-390.
17. Rose-John S, Schooltink H. 2007. Cytokines are a therapeutic target for the prevention of inflammation-induced cancers. Recent Results Cancer Res 174:57-66.
18. Samardzic T, Jankovic V, Stosic-Grujicic S, Trajkovic V. 2001. STAT1 is required for iNOS activation, but not IL-6 production in murine fibroblasts. Cytokine 13(3):179-182.
19. Sanceau J, Kaisho T, Hirano T, Wietzerbin J. 1995. Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors. J Biol Chem 270(46):27920-27931.
20. Santhanam U, Ray A, Sehgal PB. 1991. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc Natl Acad Sci USA 88(17):7605-7609.
21. Song X, Kusakari Y, Xiao CY, Kinsella SD, Rosenberg MA, Scherrer-Crosbie M, Hara K, Rosenzweig A, Matsui T. 2010. mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy. Am J Physiol Cell Physiol 299(6):C1256-C1266.
22. Stephanou A, Brar BK, Scarabelli TM, Jonassen AK, Yellon DM, Marber MS, Knight RA, Latchman DS. 2000. Ischemiainduced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis. J Biol Chem 275(14):10002-10008.
23. Stephanou A, Scarabelli TM, Townsend PA, Bell R, Yellon D, Knight RA, Latchman DS. 2002. The carboxyl-terminal activation domain of the STAT-1 transcription factor enhances ischemia/reperfusion-induced apoptosis in cardiac myocytes. FASEB J 16(13):1841-1843.
24. Suomalainen A, Elo JM, Pietilainen KH, Hakonen AH, Sevastianova K, Korpela M, Isohanni P, Marjavaara SK, Tyni T, Kiuru-Enari S, Pihko H, Darin N, Ounap K, Kluijtmans LA, Paetau A, Buzkova J, Bindoff LA, Annunen-Rasila J, Uusimaa J, Rissanen A, Yki-Jarvinen H, Hirano M, Tulinius M, Smeitink J, Tyynismaa H. 2011. FGF-21 as a biomarker for musclemanifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol 10(9):806-818.
25. Townsend PA, Scarabelli TM, Davidson SM, Knight RA, Latchman DS, Stephanou A. 2004. STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J Biol Chem 279(7):5811-5820.
26. Tsutamoto T, Hisanaga T, Wada A, Maeda K, Ohnishi M, Fukai D, Mabuchi N, Sawaki M, Kinoshita M. 1998. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 31(2):391-398.
27. Tyynismaa H, Carroll CJ, Raimundo N, Ahola-Erkkila S, Wenz T, Ruhanen H, Guse K, Hemminki A, Peltola-Mjosund KE, Tulkki V, Oresic M, Moraes CT, Pietilainen K, Hovatta I, Suomalainen A. 2010. Mitochondrial myopathy induces a starvation-like response. Hum Mol Genet 19(20):3948-3958.
28. Yamauchi-Takihara K, Ihara Y, Ogata A, Yoshizaki K, Azuma J, Kishimoto T. 1995. Hypoxic stress induces cardiac myocytederived interleukin-6. Circulation 91(5):1520-1524.